In pyruvate kinase deficiency the high activity of the leucocyte isoenzyme may mask the erythrocyte defect. Separation of leucocytes from erythrocytes by the commonly used sedimentation or filtration procedures requires rather large volumes of blood, is time-consuming, and sometimes leaves an unsatisfactorily large proportion of leucocytes. In the present study at least 9S %of leucocytes, measured with the lysosomal enzyme fJ-N-acetylhexosaminidase as a very sensitive marker for leucocyte lysis, were consistently removed by differential lysis of erythrocytes in hypotonic saline. Haemolysates suitable for erythrocyte enzyme assays can be prepared from very small quantities of capillary blood (10--100 ,.1) very rapidly, cheaply, and reproducibly by this method. Pyru\lah Klnasl! ab!lorbanc. rang. : 0·0·2 tull KGI. cl'lart !lp ••d: 2 l:m/min METHODS AND MATERIALS Pyruvate kinase was determined by a method based on that of Valentine and Tanaka (1966).
In pyruvate kinase deficiency the high activity of the leucocyte isoenzyme may mask the erythrocyte defect. Separation of leucocytes from erythrocytes by the commonly used sedimentation or filtration procedures requires rather large volumes of blood, is time-consuming, and sometimes leaves an unsatisfactorily large proportion of leucocytes. In the present study at least 9S %of leucocytes, measured with the lysosomal enzyme fJ-N-acetylhexosaminidase as a very sensitive marker for leucocyte lysis, were consistently removed by differential lysis of erythrocytes in hypotonic saline. Haemolysates suitable for erythrocyte enzyme assays can be prepared from very small quantities of capillary blood (10--100 ,.1) very rapidly, cheaply, and reproducibly by this method. 
METHODS AND MATERIALS
Pyruvate kinase was determined by a method based on that of Valentine and Tanaka (1966) . 0.50 ml triethanolamine buffer (20 mmol/l, pH 7.5, containing potassium chloride, 200 mmol/l, and magnesium sulphate, 16 mmol/l) and 0.10 ml of each of lactate dehydrogenase (180 U/ml rabbit muscle enzyme), adenosine diphosphate (12 mmol/l), and reduced nicotinamide adenine dinucleotide (2 mmol/l) were added to a 1 m1 spectrophotometer cuvette (light path 1 em), mixed and incubated at 37°C for 5 min. 0.10 m1 of each of phosphoenolpyruvate (15 rnmol/l) and haemolysate were then added, mixed, and the optical density change at 340 nm and 37°C was followed for about 2 min (Fig. 1) . The decrease in optical density in normal haemolysates prepared from normal individuals (A, B, E), a patient with pyruvate kinase deficiency (D), and his mother (C) by differential lysis. F is the blank. 263
In the congenital haemolytic disease due to pyruvate kinase deficiency the deficiency of the L (liver) isoenzyme in the erythrocytes is not accompanied by deficiency of the very high activity of the M (muscle) isoenzyme in leucocytes (Tanaka, et al., 1962) . In fact the erythrocyte defect may be masked by the leucocyte activity unless steps are taken to minimize this in the assay. This has been achieved in a number of ways including centrifugation and removal of the leucocyte-rich "buffy layer of cells" (Valentine and Tanaka, 1966) and removal of leucocytes by filtration through cotton (Busch, et al., 1969) or nylon wool (Paglia and Valentine, 1971) or by sedimentation in polyvinyl pyrrolidone (Tanaka, et al., 1962) or dextran (Gordon-Smith, 1974) .
However, these techniques require rather large quantities of blood and are time-eonsuming. Furthermore, they are never entirely successful, so that some groups have corrected for the remaining leucocyte contamination by means of cell counts and leucocyte enzyme assays (Tanaka, et al., 1962) or have minimized the contribution of the leucocyte isoenzyme by the exclusion of EDTA from the assay system (Tanphaichitr and Van Eys, 1972) . In the present study the possibility of measuring pyruvate kinase in haemolysates prepared by differential lysis of erythrocytes in hypotonic saline has been investigated. Using the lysosomal enzyme ,B-N-acetylhexosaminidase as a sensitive and specific marker for leucocyte lysis and haemoglobin for erythrocyte lysis it has been demonstrated that over 80 % of erythrocytes can be lysed while retaining at least 95 % of leucocytes intact. The method is rapid and suitable for use with very small quantities of capillary blood.
haemolysates was linear for at least 10 min when followed for this longer period. A blank, in which the haemolysate was replaced by distilled water, was also analysed, and pyruvate kinase activity was determined as /Lmol nucleotide oxidized per minute per litre haemolysate (U/I) and subsequently was referred to the haemoglobin concentration of the haemolysate (U/g Hb).
Haemoglobin was determined by the cyanmethaemoglobin method (International Committee for Standardization in Haematology, 1965).0.10 ml haemolysate was added to 1.0 ml ferricyanide reagent (potassium ferricyanide, 0.6 mmol/l, pH 7.0, containing potassium cyanide, 0.8 mmol/l, potassium dihydrogen orthophosphate, 1 mmol/l, and Nonidet P. 42 B.D.H. detergent, 0.1 % by volume), and the optical density at 540 nm was measured after 5 min at room temperature. Haemoglobin concentration was calculated as grams per litre of haemolysate (g/I).
,B-N-acetylhexosaminidase was assayed using the substrate 4-methylumbelliferyl.2-acetamido-2-deoxy-,8-D-glucopyranoside (Leaback and Walker, 1961) . 0.10 ml haemolysate (or distilled water for the blank) was incubated with 0.50 rnl buffered substrate solution (0.90 g substrate per litre citrate buffer, 0.06 mol/I, pH 4.5) at 37°C for exactly 60 min. 0.50 ml perchloric acid solution (2 molfI) was then added and the precipitated proteins removed by centrifugation at 2000 g for 10 min. 4-Methylumbelliferone in 0.50 ml supernatant was then determined by adding 2.0 ml glycine buffer (0.5 mol/l, pH 10.5) and comparing the fluorescence, measured using excitation and emission wavelengths of 365 nm and 450 nm respectively, with that of standards containing 0--25 nmol 4-methylumbelliferone. The enzyme activity was expressed as /Lmol 4-methyl-umbeIIiferone released per minute per litre haemolysate (U/I).
Haemolysates were prepared by mixing 0.10 ml whole blood with 2.5 rnl hypotonic saline (0--5 g/I), followed by restoration of isotonicity after a timed interval (0--10 min) by addition of 0.50 ml hypertonic saline (29-54 g/I). Intact cells and debris were then removed by centrifugation at 1000 g for 5 min. Haemoglobin, ,B-N-acetylhexosaminidase, and pyruvate kinase were determined in the supernatants, and their concentrations compared with those in total cell Iysates prepared by mixing 0.10 ml whole blood with 3.0 ml distilled water and freezing and thawing three times.
Since centrifugation and sedimentation techniques are commonly used to prepare erythrocytes for pyruvate kinase assays, two of these were also briefly investigated. Whole blood was centrifuged at 1000 g for 5 min, and the leucocyte-rich buffy layer of cells was carefully removed with a Pasteur pipette. Alternatively, 2.5 ml whole blood was mixed with 5.0 ml dextran T-110 solution (30 g/I in isotonic saline), and the leucocyte-rich supernatant was removed from the sedimented erythrocytes after 30 min. The separated erythrocytes, in both methods, were washed three times in an approximately equal volume of isotonic saline, and leucocyte counts were made using an electronic particle counter.
RESULTS AND DISCUSSION
In the present study the separation of leucocytes from erythrocytes by centrifugation or dextran sedimentation removed only 30--90% and 80--90% of leucocytes respectively (Table I) . Since in normal blood leucocytes contribute about one-third of the total pyruvate kinase activity (see below), 3-25 % of the measured activity in haemolysates prepared using these techniques will be due to the leucocyte isoenzyme. These methods also require rather large volumes of blood, so the possibility of preparing haemolysates containing less leucocyte isoenzyme from very small volumes of blood by differential lysis of erythrocytes in hypotonic saline was investigated.
To determine the most appropriate hypotonic saline concentration whole blood from each of 12 apparently normal individuals was mixed with saline solutions varied in concentration from 0 to 5 gIl. Isotonocity was restored after 10 min by the addition of hypertonic saline solutions of the appropriate concentration to give a final concentration of9 gIl. Haemoglobin (erythrocyte lysis marker), ,B-N-acetylhexosaminidase (leucocyte lysis marker), and pyruvate kinase were then determined in the supernatants and expressed as percentages of the concentrations in the total cell lysates (Fig. 2) .
Over 85 % of erythrocytes were lysed in saline concentrations below 3 g/I, while less than 20 % of leucocytes were lysed in concentrations greater than 2 g/1. Pyruvate kinase activity, expressed as U/g Hb, was higher at the lower saline concentrations, presumably owing to the presence of increasing amounts of the leucocyte enzyme, and, like haemoglobin concentration, was very variable in saline concentrations above 3 g/I ( Table 2) .
The effect of varying the time of exposure of the cells to hypotonicity was investigated by means of a saline concentration of 3 g/1. Whole blood from each of eight apparently normal individuals was mixed with the hypotonic saline, and isotonicity was restored by adding the hypertonic saline after intervals varied between lOs and 10 min. Haemoglobin, ,B-N-acetylhexosaminidase, and pyruvate kinase were then determined in the supernatants and expressed as percentages of the concentration in total cell Iysates (Fig. 3) . Over 70% of the erythrocyte marker was released into the
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Differential erythrocyte lysis
As a result of these investigations the conditions selected for differential erythrocyte lysis were 1 min exposure to hypotonic saline of concentration 2.5 gil. These conditions were then more fully examined by preparing haemolysates (and total cell lysates for comparison) from blood samples of 34 apparently normal individuals (Fig. 4 ). Approximately 86 % of erythrocytes (95 % limits 77-95 %) and 3.5 % of leucocytes (95 % limits 1.7--6.9 %) were lysed in these conditions, and pyruvate kinase activity, determined in 85 normal haemolysates, was 14.5 Dig Hb (95 % limits 8.0-20.8) or 64 % of the total cell lysate activity (95 % limits 37-91 %). The error due to the leucocyte isoenzyme by this method will therefore be of the order of 1-2 % in normal individuals.
The reproducibility of the method was estimated by determining the pyruvate kinase activity in 25 haemolysates prepared from the same blood sample. The mean activity was 15.02 V/g Hb, with a standard deviation of 0.48 and coefficient of variation (within-batch) of 3.20%. While haemolysates for pyruvate kinase or glucose-6-phosphate supernatant within the first minute of exposure to hypotonicity, compared with less than 7 %of the leucocyte marker. The latter continued to rise slightly, however, for the whole 10 min period, while little further erythrocyte lysis took place. Pyruvate kinase activity, expressed as Dig Hb, was stable during the whole 10 min period (Table 3) .s c 50 100 determinations are normally prepared from 0.10 ml of whole blood, the method can be scaled down for use with as little as 0.01 ml should this be the maximum available.
Pyruvate kinase activities in haemolysates, prepared by differential lysis, from two patients with congenital non-spherocytic anaemia were 13.3 and 19.2 % respectively of the normal mean (Table 4) Fig. 1 ). With the other methods of leucocyte separation both the patients and their parents had apparently considerably higher activities, and diagnosis of the erythrocyte deficiency may not have been made (Table 4 ). Even when differential lysis was used to prepare haemolysates, the activities in the parents overlap with those of normal individuals, so that the genotype of a sib (Sib B in Table 4 ) of one of the patients could not be determined with confidence. When more heterozygotes are available for study it will, however, be possible to determine the probability that this sib is heterozygous (Westwood and Raine, 1975 
SHORT REPORT
Some Problems in the Use of "Vacutainers"
Alternatives to the conventional syringe and specimen tube for the collection and transmission of blood specimens have been devised from time to time, with varying success. A recent paper (Ames and Bamford, 1975) sets out some features of the Vacutainer system (Becton Dickinson & Company), available in the U.K. since about 1965, but does not lay much stress on certain practical disadvantages, which are perhaps more obvious to the clinical user than to the laboratory worker.
CoNCLUSIONS FROM TESTS
Problems which became apparent when the system was tested in Aberdeen in 1965 resulted in a unanimous preference being expressed for the conventional syringe, and while the manufacturers have made a number of small changes since then, most of the points raised at that time appear to be still valid. They are as follows.
(a) The plastic carrier has a central needle mount. This matters little in the smaller size, but in the standard carrier it brings the same disadvantages as are seen if a large syringe has a central nozzle.
(b) The needle carrier is generally regarded as reusable, but it is liable to be contaminated by blood when the double-ended needle is unscrewed for replacement. The outside of the tube stopper also shows blood contamination, usually minor, and this is probably unavoidable since the inner orifice of the needle must touch the outside of the stopper on withdrawal. The manufacturer's latest version of the sleeved multisample needle (mentioned by Ames and Bamford) may possibly reduce the scale of such contamination but can hardly hope to eliminate it.
(c) Considerable pressure is needed to push the evacuated tube on to the short end of the needle (between 1.5 and 2.3 kg in batches bench-tested here), and, since this must be done while keeping the point of the needle in the lumen of the vein, appreciably more skill is needed than with the normal syringe if dislodged needles, haematomas, and repeat punctures are to be avoided. (d) Since one cannot be sure that the needle point is in the lumen of the vein until the evacuated tube is pushed fully home and blood is seen to flow, the problem presented by the patient with small, collapsed, or deep-set veins is greater than with a syringe, where gentle trial-and-error aspirations can be easily repeated when in difficulty. (The Vacutainer appears unsuitable for arterial sampling for similar reasons.) (e) The stoppers are of necessity a tight fit in the tube necks and are of stout rubber. This has the advantage of virtually eliminating leakage in transit, but makes the stoppers difficult to remove and so leads to greater dispersion of blood droplets or aerosols in the laboratory.
(I) The tubes have a uniformly satisfactory degree ofvacuum when taken from a freshly opened vacuum
